Primary breast lymphoma : The role of mastectomy and the importance of lymph node status

Primary breast lymphoma : The role of mastectomy and the importance of lymph node status

To construct and analyze a database comprised of all reported cases of primary breast lymphoma (PBL) that include treatment and follow-up information published during the last 3 decades. PBL accounts for 0.4% of breast malignancies and 2% of extranodal lymphomas. Surgical therapy has varied from bio...

Full description

Saved in:
Bibliographic Details
Published in:Annals of surgery Vol. 245; no. 5; pp. 784 - 789
Main Authors: JENNINGS, William C, BAKER, Randal S, MURRAY, Sunshine S, HOWARD, C. Anthony, PARKER, Donald E, PEABODY, Linda F, VICE, Heather M, SHEEHAN, William W, BROUGHAN, Thomas A
Format: Journal Article
Language:English
Published: Hagerstown, MD Lippincott 01-05-2007
Subjects:
Adolescent
Adult
Aged
Aged, 80 and over
Axilla
Biological and medical sciences
Breast Neoplasms - mortality
Breast Neoplasms - pathology
Breast Neoplasms - therapy
Databases, Factual
Female
Follow-Up Studies
General aspects
Hematologic and hematopoietic diseases
Humans
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymph Nodes - pathology
Lymphoma - mortality
Lymphoma - pathology
Lymphoma - therapy
Mastectomy
Medical sciences
Middle Aged
Original
Retrospective Studies
Survival Rate
Treatment Outcome
Medicine
Treatment
Lymph node
Lymphoproliferative syndrome
Surgery
Primary
Mastectomy
Breast
Malignant hemopathy
Mammary gland
Lymphoid neoplasm
Lymphoma
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To construct and analyze a database comprised of all reported cases of primary breast lymphoma (PBL) that include treatment and follow-up information published during the last 3 decades. PBL accounts for 0.4% of breast malignancies and 2% of extranodal lymphomas. Surgical therapy has varied from biopsy to radical mastectomy. Chemotherapy and radiation therapy have been used as adjuvant or primary therapy. A standard consensus treatment of PBL is not available. We reviewed all published PBL reports from June 1972 to March 2005. A database was compiled by abstracting individual patient information, limiting our study to those reports that contained specific treatment and outcome data. Patient demographics such as survival, recurrence, and time to follow-up were recorded, in addition to surgical, radiation, and/or chemotherapy treatment(s). We found 465 acceptable patients reported in 92 publications. Age range was 17 to 95 years (mean, 54 years). Mean tumor size was 3.5 cm. Diffuse large cell (B) lymphoma was the most common histologic diagnosis (53%). Disease-free survival was 44.5% overall. Follow-up ranged from one to 288 months (mean, 48 months). Treatment by mastectomy offered no survival benefit or protection from recurrence. Treatment that included radiation therapy in stage I patients (node negative) showed benefit in both survival and recurrence rates. Treatment that included chemotherapy in stage II patients (node positive) showed benefit in both survival and recurrence rates. Histologic tumor grade predicted survival. Mastectomy offers no benefit in the treatment of PBL. Nodal status predicts outcome and guides optimal use of radiation and chemotherapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0003-4932
1528-1140
DOI:10.1097/01.sla.0000254418.90192.59